CBD Global Sciences Inc.

CBDNFOTCHealthcare

$0.04

$-0.00(-2.67%)

Market Cap$2072232

P/E Ratio—

52W High$0.121

52W Low$0.016

Avg Volume7K

Open$0.04

Beta0.43

Revenue Financials Earnings

CBD Global Sciences Inc. (CBDNF) Revenue

Annual & quarterly revenue history · segment & region breakdown

CBDNF · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

CBD Global Sciences Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 45.33% year-over-year from $0.00B in FY2021.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

-45.33%

vs FY2021 $0.00B

Price / sales

2.94×

mktCap ÷ TTM rev

Revenue per day

$0M

Est. TTM ÷ 365

Revenue / employee

—

0 employees

FY2021

$0.00B

FY2020

$0.00B

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · CBD Global Sciences Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

2021 – 2019 · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth
2021-12-31	$0.00B	-$0.00B	-45.33%
2020-12-31	$0.00B	-$0.00B	-86.82%
2019-12-31	$0.00B	—	—

CBDNF revenue by year · CBDNF revenue history · CBDNF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income CBD Global Sciences Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

CBD Global Sciences Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from CBD Global Sciences Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

CBDNF revenue · 4 questions

CBDNF's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 45.33% year-over-year from $0.00B in FY2021.

CBDNF revenueCBDNF annual revenuewhat is CBDNF revenueCBDNF TTM revenue

▸ Source: FMP · CBD Global Sciences Inc. SEC filings · GAAP · CBD Global Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026